• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


Price not available for APNSF:US

Snapshot for Aposense Ltd (APNSF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.2500 52wk Range: 0.2100 - 0.2500 1-Yr Rtn: -

Stock Chart for APNSF

No chart data available.
  • APNSF:US 0.2500
  • 1M
  • 1Y
Interactive APNSF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APNSF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 26.53
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APNSF

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for APNSF

Aposense Limited is a clinical stage molecular imaging and drug development company. The Company has a pipeline of products based on its patented platform technology used for targeting apoptosis. Aposense Ltd targets multiple disease categories including oncology, cardiology, and neurology.

Miri Ben-AmiChief Executive OfficerDov FarkashChief Financial Officer
More Company Profile & Key Executives for APNSF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil